Bicocca Open Archive

Logo unimib boa
CROTTI, LIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 20.771
AS - Asia 14.071
EU - Europa 9.893
SA - Sud America 2.014
Continente sconosciuto - Info sul continente non disponibili 1.355
AF - Africa 332
OC - Oceania 71
Totale 48.507
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.368
SG - Singapore 4.947
IT - Italia 3.359
CN - Cina 2.704
HK - Hong Kong 2.084
VN - Vietnam 2.028
RU - Federazione Russa 1.666
BR - Brasile 1.474
CA - Canada 1.152
IE - Irlanda 881
DE - Germania 823
SE - Svezia 746
GB - Regno Unito 556
BD - Bangladesh 451
FR - Francia 441
IN - India 353
ID - Indonesia 302
UA - Ucraina 243
AR - Argentina 219
KR - Corea 208
ES - Italia 178
NL - Olanda 174
JP - Giappone 172
FI - Finlandia 165
TR - Turchia 144
AT - Austria 136
IQ - Iraq 136
MX - Messico 125
ZA - Sudafrica 106
PL - Polonia 91
CO - Colombia 78
DK - Danimarca 73
PK - Pakistan 71
CH - Svizzera 70
EC - Ecuador 70
SA - Arabia Saudita 64
PH - Filippine 61
AU - Australia 56
CL - Cile 50
VE - Venezuela 48
BE - Belgio 47
MA - Marocco 44
UZ - Uzbekistan 40
GR - Grecia 39
MY - Malesia 33
JM - Giamaica 32
KE - Kenya 32
PT - Portogallo 31
ET - Etiopia 30
LT - Lituania 28
PY - Paraguay 27
TH - Thailandia 27
AE - Emirati Arabi Uniti 26
TW - Taiwan 25
RO - Romania 23
CZ - Repubblica Ceca 22
JO - Giordania 22
TN - Tunisia 22
DZ - Algeria 20
AZ - Azerbaigian 19
EG - Egitto 19
PE - Perù 19
UY - Uruguay 19
IL - Israele 18
RS - Serbia 18
CR - Costa Rica 16
KZ - Kazakistan 16
NP - Nepal 16
GT - Guatemala 14
IR - Iran 14
NZ - Nuova Zelanda 14
OM - Oman 13
SN - Senegal 13
HN - Honduras 12
KW - Kuwait 12
AL - Albania 11
BY - Bielorussia 11
DO - Repubblica Dominicana 11
HR - Croazia 9
NG - Nigeria 9
BA - Bosnia-Erzegovina 8
BG - Bulgaria 8
HU - Ungheria 8
KG - Kirghizistan 8
SC - Seychelles 8
LB - Libano 7
NO - Norvegia 7
PS - Palestinian Territory 7
TT - Trinidad e Tobago 7
BH - Bahrain 6
BO - Bolivia 6
GE - Georgia 6
PA - Panama 6
AM - Armenia 5
LK - Sri Lanka 5
NI - Nicaragua 5
PR - Porto Rico 5
SI - Slovenia 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
Totale 47.073
Salva come PNG Salva come JPEG
Città #
Singapore 2.819
Hong Kong 2.038
Ashburn 1.747
Fairfield 1.558
Ann Arbor 1.273
San Jose 1.052
Milan 1.036
Toronto 942
Dublin 825
Chandler 741
Woodbridge 700
Santa Clara 698
Wilmington 683
Houston 639
New York 633
Ho Chi Minh City 624
Seattle 618
Hanoi 506
Dearborn 502
Cambridge 497
Frankfurt am Main 474
Chicago 449
Dallas 401
Council Bluffs 380
Princeton 368
Los Angeles 353
Rome 326
The Dalles 322
Hefei 293
Beijing 285
Jakarta 239
Lauterbourg 217
Seoul 179
Nanjing 174
Jacksonville 164
Lawrence 161
Moscow 157
Altamura 152
Buffalo 151
São Paulo 141
San Diego 112
Helsinki 105
London 99
Tokyo 98
Guangzhou 94
Vienna 94
Nuremberg 93
Boardman 92
Da Nang 90
Shanghai 86
Atlanta 85
Orem 73
Haiphong 71
Turin 71
Columbus 67
Phoenix 67
Shenyang 63
Warsaw 63
Denver 60
Hebei 60
Salt Lake City 60
Jinan 59
Andover 58
Montreal 58
Munich 56
Nanchang 56
San Francisco 55
Boston 53
Brooklyn 52
Baghdad 51
Figino 51
Hangzhou 51
Chennai 49
Changsha 48
Rio de Janeiro 48
Amsterdam 47
Belo Horizonte 44
Zhengzhou 43
Johannesburg 42
Madrid 42
Naples 42
Dhaka 41
Tianjin 38
Istanbul 36
Washington 36
Biên Hòa 35
Dong Ket 35
Florence 35
Lappeenranta 35
Sesto San Giovanni 34
Tashkent 34
Buenos Aires 33
Jiaxing 33
Bologna 32
Stockholm 32
Tampa 32
Elk Grove Village 31
Miami 31
Hải Dương 30
Mexico City 30
Totale 28.868
Salva come PNG Salva come JPEG
Nome #
Indications and utility of cardiac genetic testing in athletes 629
Genetic mechanisms of critical illness in COVID-19 569
International Triadin Knockout Syndrome Registry: The Clinical Phenotype and Treatment Outcomes of Patients with Triadin Knockout Syndrome 534
Continuous Rhythm Monitoring With Implanted Loop Recorders in Children and Adolescents With Brugada Syndrome 507
MTMR4 SNVs modulate ion channel degradation and clinical severity in congenital long QT syndrome: insights in the mechanism of action of protective modifier genes 499
Elucidating arrhythmogenic mechanisms of long-QT syndrome CALM1-F142L mutation in patient-specific induced pluripotent stem cell-derived cardiomyocytes 479
Calmodulinopathy: A Novel, Life-Threatening Clinical Entity Affecting the Young 456
Therapeutic Efficacy of Mexiletine for Long QT Syndrome Type 2: Evidence from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes, Transgenic Rabbits, and Patients 452
NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis 423
From patient-specific induced pluripotent stem cells to clinical translation in long QT syndrome Type 2 388
Mapping the human genetic architecture of COVID-19 370
Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy 361
Calmodulinopathy: Functional Effects of CALM Mutations and Their Relationship With Clinical Phenotypes 358
Investigation on Sudden Unexpected Death in the Young (SUDY) in Europe: results of the European Heart Rhythm Association Survey 343
Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome. 335
Clinical management of catecholaminergic polymorphic ventricular tachycardia the role of left cardiac sympathetic denervation 334
Pulmonary hypertension due to a stiff left atrium: Speckle tracking equivalents of large V-waves 324
Long QT Syndrome and Brugada Syndrome : 2 aspects of the same disease? 314
Condizioni cliniche associate ad anomalie dell'intervallo QT: Implicazioni cliniche [Clinical conditions associated with abnormal QT interval: clinical implications] 300
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi003-A from a patient affected by an autosomal recessive form of Long QT Syndrome type 1 286
Partial Pericardial Agenesis Mimicking Arrhythmogenic Right Ventricular Cardiomyopathy 273
The expression of the rare caveolin-3 variant T78M alters cardiac ion channels function and membrane excitability 270
Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome 269
Exercise Training-Induced Repolarization Abnormalities Masquerading as Congenital Long QT Syndrome 262
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy 259
Identification of a targeted and testable antiarrhythmic therapy for long-QT syndrome type 2 using a patient-specific cellular model 254
Biventricular arrhythmogenic cardiomyopathy: a paradigmatic case. 253
AKAP9 is a genetic modifier of congenital long-QT syndrome type 1 238
Metabolic adaptations to cardiac rehabilitation through physical exercise: Insights from untargeted metabolomics using dried blood spots in post-myocardial infarction patients 237
Infanticide vs. inherited cardiac arrhythmias. 234
An International Multicenter Evaluation of Type 5 Long QT Syndrome: A Low Penetrant Primary Arrhythmic Condition 227
Prevalence of the congenital long-qt syndrome 226
Efficacy and safety of cardiac rehabilitation in patients with left ventricular thrombosis after acute myocardial infarction 225
Clinical Implications for Patients With Long QT Syndrome Who Experience a Cardiac Event During Infancy 224
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 223
Role of common and rare variants in SCN10A: results from the Brugada syndrome QRS locus gene discovery collaborative study 223
Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls 223
Autonomic control of heart rate and QT interval variability influences arrhythmic risk in long QT syndrome type 1 222
Razionale e valore fondamentale della Rete Italiana integrata dell’Amiloidosi Cardiaca [Rationale and significance of the Italian Network for Cardiac Amyloidosis] 221
Clinical presentation of calmodulin mutations: the International Calmodulinopathy Registry 220
The ICD for the long QT syndrome: which indications, complications, and results? 218
Invasive Hemodynamics of Hypertrophic Cardiomyopathy: Exercise Versus Isoproterenol 218
An explainable model of host genetic interactions linked to COVID-19 severity 217
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5 216
ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study 214
The KCNH2-IVS9-28A/G mutation causes aberrant isoform expression and hERG trafficking defect in cardiomyocytes derived from patients affected by Long QT Syndrome type 2 214
The Common Long QT Syndrome mutation KCNQ1/A341V causes unusually severe clinical manifestations in patients with different ethnic backgrounds: toward a mutation-specific risk stratification 213
A Primary Prevention Clinical Risk Score Model for Patients With Brugada Syndrome (BRUGADA-RISK) 212
Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families 210
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 210
Clinical Features, Long-Term Prognosis, and Clinical Management of Genotype-Negative Long QT Syndrome Patients 209
The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome 208
Whole-genome sequencing reveals host factors underlying critical COVID-19 207
Calmodulin mutations and life-threatening cardiac arrhythmias: Insights from the International Calmodulinopathy Registry 205
The genetics underlying acquired long QT syndrome: Impact for genetic screening 203
The genetics underlying idiopathic ventricular fibrillation: A special role for catecholaminergic polymorphic ventricular tachycardia? 203
Generation of the human induced pluripotent stem cell (hiPSC) line PSMi002-A from a patient affected by the Jervell and Lange-Nielsen syndrome and carrier of two compound heterozygous mutations on the KCNQ1 gene 203
Mutation analysis of the phospholamban gene in 315 South Africans with dilated, hypertrophic, peripartum and arrhythmogenic right ventricular cardiomyopathies 203
Long and Short QT syndromes. 203
Neuroimmune crosstalk in the pathophysiology of hypertension. 203
A novel rare variant in SCN1Bb linked to Brugada syndrome and SIDS by combined modulation of Nav1.5 and Kv4.3 channel currents 202
To be, or not to be engaged in sport activities, that is the amletic question for patients with coronary artery disease 202
Response to Letters Regarding Article, "clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation" 201
aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study 200
Response by Crotti et al to Letter Regarding Article, "genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1?" 200
The elusive link between LQT3 and Brugada syndrome: the role of flecainide challenge 200
Does pregnancy increase cardiac risk for LQT1 patients with the KCNQ1-A341V mutation? 200
The Long QT Syndrome 200
Corrigendum to “Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis” [International Journal of Cardiology Volume 357, 15 June 2022, Pages 88–94]. (International Journal of Cardiology (2022) 357 (88–94), (S0167527322003850), (10.1016/j.ijcard.2022.03.028)) 199
Inherited Cardiac Arrhythmia Syndrome: Role of Potassium Channels 198
Gain of function mutation, S422L, in the KCNJ8-encoded cardiac K ATP channel Kir6.1 as a pathogenic substrate for J wave syndromes 198
The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome 198
SCN5A mutations in 442 neonates and children: genotype-phenotype correlation and identification of higher-risk subgroups. 198
Brugada and Long QT Syndrome are two different diseases: True or False? 197
KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome 197
Frequency of and outcomes associated with nonadherence to guideline-based recommendations for an implantable cardioverter-defibrillator in patients with congenital long QT syndrome 194
Novel calmodulin mutations associated with congenital long QT syndrome affect calcium current in human cardiomyocytes 194
Arrhythmogenic calmodulin mutations disrupt intracellular cardiomyocyte Ca2+ regulation by distinct mechanisms 194
A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome 193
Genetic Modifiers for the Long-QT Syndrome: How Important Is the Role of Variants in the 3′ Untranslated Region of KCNQ1? 192
Multiscale complexity analysis of the cardiac control identifies asymptomatic and symptomatic patients in long QT syndrome type 1 192
Cardiac potassium channel dysfunction in sudden infant death syndrome 192
Multiplexed Assays of Variant Effect and Automated Patch Clamping Improve KCNH2-LQTS Variant Classification and Cardiac Event Risk Stratification 191
QTc behavior during exercise and genetic testing for the long-QT syndrome 191
Desmoplakin missense and non-missense mutations in arrhythmogenic right ventricular cardiomyopathy: Genotype-phenotype correlation 191
Gene symbol: KCNH2. Disease: Long QT syndrome in Novel human pathological mutations 190
Mutation-Specific Risk in Two Genetic Forms of Type 3 Long QT Syndrome 190
Impact of clinical and genetic findings on the management of young patients with Brugada syndrome 189
Neural control of heart rate is an arrhythmia risk modifier in long QT syndrome 189
The role of genetics in primary ventricular fibrillation, inherited channelopathies and cardiomyopathies 188
Cardiac sodium channel dysfunction in sudden infant death syndrome 188
Unexplained sudden cardiac arrest in children: clinical and genetic characteristics of survivors 187
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 186
Cardiac arrhythmias of genetic origin are important contributors to Sudden Infant Death Syndrome 185
Low-pass filtering approach via empirical mode decomposition improves short scale entropy-based complexity estimation of QT interval variability in Long QT Syndrome Type 1 patients 184
Use of hiPSC-Derived Cardiomyocytes to Rule Out Proarrhythmic Effects of Drugs: The Case of Hydroxychloroquine in COVID-19 183
Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population 181
Ion channel diseases in children: Manifestations and management 181
PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic basis 180
Abnormal myocardial expression of SAP97 is associated with arrhythmogenic risk 179
Totale 24.927
Salva come PNG Salva come JPEG
Categoria #
all - tutte 170.964
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 170.964
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.756 0 163 235 85 61 117 117 152 95 208 221 302
2022/20233.996 425 913 301 350 274 652 92 261 354 65 169 140
2023/20243.086 124 162 157 89 420 709 509 107 300 92 79 338
2024/20258.756 466 1.208 617 332 622 347 456 358 1.061 1.102 673 1.514
2025/202620.120 1.772 1.303 1.285 1.696 2.059 1.051 2.567 964 2.084 1.629 1.749 1.961
2026/20271.661 1.258 403 0 0 0 0 0 0 0 0 0 0
Totale 48.507